- Home
- Drug Discovery And Development Industry
- Actelion Pharmaceuticals Market and Forecasts, May 2012
Talk to Sam
+1 917 267 7886
Industries
Top countries
Publication dates
All regions
data types
Actelion Pharmaceuticals Market and Forecasts, May 2012
industry reports
country reports
company reports
Investor presentation: Pathology in The United States, Japan and The United Kingdom for Year 2011
- Company report
- March 2011
- 27 pages
... pharmaceuticals ltd Growth due to price movement 8% Decline in units shipped Continuing competitive market Leveraging superior efficacy label vs. Other inhaled prostacyclins managing a competitive ...
- Industries: Pathology
- Countries: United States, Japan, United Kingdom
Company Report: Drug and Medication in The United States and Canada for Year 2011
- Company report
- March 2011
- 8 pages
... With lipodystrophy was filed in june 2011 with health canada and is also under review. On february 20, 2012, we granted actelion pharmaceuticals canada inc., Or actelion, exclusive commercialization rights ...
- Industries: Drug and Medication
- Countries: United States, Canada, World
Company Report: Drug Discovery and Development in The United States for Year 2011
- Company report
- December 2011
- 209 pages
... Generic and proprietary products to treat serious diseases include: actelion pharmaceuticals, bayer health care, biogen idec, eli lilly & co., Genzyme, glaxosmithkline pharmaceuticals, merck & co., Pfizer ...
- Industries: Drug Discovery and Development
- Countries: United States
BioSpecifics Technologies Corp. - Company Report for Year 2011
- Company report
- December 2011
- 201 pages
... The right to commercialize xiaflex for the treatment of duputyren S contracture and peyronie S disease in japan. Auxilium also has an agreement with actelion pharmaceuticals ltd. ( Actelion ) Pursuant ...
- Industries: Drug Discovery and Development
- Countries: United States
Company Report: Generic Drug in The United States and France for Year 2012
- Company report
- May 2012
- 7 pages
- by Corporation
... actelion pharmaceuticals ltd / actelion to host company update conference call / audiocast . Processed and transmitted by thomson reuters one. The issuer is solely responsible for the content ...
- Industries: Generic Drug
- Countries: United States, France
Shire PLC - Annual Report 2011
- Company report
- December 2011
- 321 pages
... And watson pharmaceuticals inc. The comparator group set at the time of award for the 2009 awards was actelion pharmaceuticals ltd., Amgen inc., Biomarin pharmaceutical inc., Biogen idec inc., Biovail ...
- Industries: Pathology
- Countries: United States
Company Report: Building and Engineering for Year 2011
- Company report
- April 2011
- 82 pages
... Hilti family trust. He was named to the board of directors of actelion pharmaceuticals ltd., Allschwil, in 2009. Dr. Tis prager zumikon, switzerland tis prager (born 1948; re-elected until the 2013 ...
- Industries: Building and Engineering
Gilead Sciences Inc. - Annual Report 2011
- Company report
- December 2011
- 178 pages
... By actelion pharmaceuticals us, inc. (Actelion) and indirectly with a pah product from united therapeutics corporation. Ranexa competes predominantly with generic compounds from three distinct classes of drugs ...
- Industries: Drug and Medication
- Countries: United States
Switzerland: Brief Outlook, 2012-2015
- Country report
- May 2012
- 3 pages
... Roland haefeli senior vice president, head of investor relations & public affairs actelion pharmaceuticals ltd, gewerbestrasse 16, ch-4123 allschwil +41 61 565 62 62 +1 650 624 69 36 www ...
- Countries: Switzerland
The United States: Country Report, 2012-2016
- Country report
- March 2012
- 72 pages
... Operating officer of centocor inc., When j&j acquired the company. Mr. Scodari was a director of actelion pharmaceuticals, ltd., A pharmaceuticals company until may 2011. Mr. Scodari is a director of endo ...
- Countries: United States
Reportlinker.com © Copyright 2012. All rights reserved
